Phathom Pharmaceuticals, Inc. (PHAT)
11.87
-1.18
(-9.04%)
USD |
NASDAQ |
May 15, 16:00
11.87
0.00 (0.00%)
After-Hours: 20:00
Phathom Pharmaceuticals Total Assets (Quarterly) : 305.12M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.422B |
| Ligand Pharmaceuticals, Inc. | 1.532B |
| Axsome Therapeutics, Inc. | 713.61M |
| Corcept Therapeutics, Inc. | 814.88M |
| Assertio Holdings, Inc. | 211.30M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 642.08M |
| Shareholders Equity (Quarterly) | -336.96M |
| Debt to Equity Ratio | -1.624 |
| Current Ratio | 2.212 |
| Net Debt Paydown Yield | 0.18% |